Literature DB >> 6782204

Chelatable lead body burden (by calcium-disodium EDTA) and blood lead concentration in man.

J P Hansen, M Døssing, P E Paulev.   

Abstract

The cheletable part of lead body burden was measured in 32 workers and seven office workers after an infusion test with CaNa2EDTA. The workers had been exposed to lead at a lead and zinc processing unit for one to three years (mean one year). There was good correlation (r = 0.87) between blood lead and chelatable urinary lead excretion described by the equation y = 0.07 . 10(0.46.x). From this equation it can be predicted that the generally accepted limit value for chelatable urinary lead excretion, 0.42 mumol/mmol CaNa2EDTA administered per 24 hours (3.1 mumol/24 hours or 650 micrograms/24 hours), corresponds to a blood lead concentration (PbB) of 1.7 mumol/l (or 35 micrograms/100 ml), which is lower than the commonly accepted limit value of 2.9 mumol/l (or 60 micrograms/100 ml) for occupationally lead-exposed persons. There was a better correlation between the cheletable lead excretion and the urinary ALA-excretion (r = 0.45; p less than 0.001) than between PbB and the urinary ALA-excretion (r = 0.26; p greater than 0.05).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6782204     DOI: 10.1097/00043764-198101000-00017

Source DB:  PubMed          Journal:  J Occup Med        ISSN: 0096-1736


  7 in total

1.  Mobilisation of heavy metals into the urine by CaEDTA: relation to erythrocyte and plasma concentrations and exposure indicators.

Authors:  S Araki; H Aono; K Murata
Journal:  Br J Ind Med       Date:  1986-09

2.  L-line x-ray fluorescence of cortical bone lead compared with the CaNa2EDTA test in lead-toxic children: public health implications.

Authors:  J F Rosen; M E Markowitz; P E Bijur; S T Jenks; L Wielopolski; J A Kalef-Ezra; D N Slatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  delta-Aminolevulinic acid dehydratase genotype modifies four hour urinary lead excretion after oral administration of dimercaptosuccinic acid.

Authors:  B S Schwartz; B K Lee; W Stewart; P Sithisarankul; P T Strickland; K D Ahn; K Kelsey
Journal:  Occup Environ Med       Date:  1997-04       Impact factor: 4.402

4.  Lead poisoning: clinical, biochemical, and haematological aspects of a recent outbreak.

Authors:  A Pagliuca; G J Mufti; D Baldwin; A N Lestas; R M Wallis; A J Bellingham
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

5.  Provocative chelation with DMSA and EDTA: evidence for differential access to lead storage sites.

Authors:  B K Lee; B S Schwartz; W Stewart; K D Ahn
Journal:  Occup Environ Med       Date:  1995-01       Impact factor: 4.402

Review 6.  Lead intoxication.

Authors:  L S Ibels; C A Pollock
Journal:  Med Toxicol       Date:  1986 Nov-Dec

7.  Comparison of measures of lead exposure, dose, and chelatable lead burden after provocative chelation in organolead workers.

Authors:  B S Schwartz; M P McGrail; W Stewart; T Pluth
Journal:  Occup Environ Med       Date:  1994-10       Impact factor: 4.402

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.